WHO pauses hydroxychloroquine trial over safety concerns

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday. Gavino Garay has more.

from Reuters Video: Politics https://ift.tt/2XsmP3g
via mediacitygroups.blogspot.com